Lausanne University Hospital (CHUV) at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
Lausanne University Hospital (CHUV) takes part in 6 sessions at ESMO 2026 in Madrid. Its sessions focus on head and neck cancer and lung cancer, including small cell lung cancer, HER2-mutant non-small cell lung cancer and cancer vaccines. It presents a phase III trial comparing swallowing function and side effects after transoral surgery or radiotherapy in early throat cancers, and discusses DLL3-targeted T-cell engagers.
| Organization | ESMO 2026 Attendance |
|---|---|
Lausanne University Hospital (CHUV) Lausanne, Switzerland | |
Teaching hospital of the University of Lausanne, Switzerland. | Satellite Sat Oct 24 13:00–14:30 MSD - Practical MDT Considerations for the new Treatment Paradigm in Resectable LA HNSCC Sarcoma, CNS, head & neck and rare cancers Satellite Sat Oct 24 13:00–13:10 Welcome and Introduction Sarcoma, CNS, head & neck and rare cancers Satellite Sat Oct 24 13:40–14:10 MDT Case Discussion Sarcoma, CNS, head & neck and rare cancers Abstract Sun Oct 25 09:28–09:38 Abstract Sun Oct 25 11:13–11:23 Satellite Sun Oct 25 13:00–14:30 PEAK Medicals - Lung Summit on SCLC: From IO- Standards to the TCE Era Lung & thoracic cancers Satellite Sun Oct 25 13:00–13:05 Welcome & Introduction to Lung Summit on SCLC Lung & thoracic cancers Satellite Sun Oct 25 13:20–13:40 Redefining the Standards: The Era of DLL3 T-Cell Engagers Lung & thoracic cancers Satellite Sun Oct 25 14:15–14:30 Faculty Roundtable and Audience Q&A Lung & thoracic cancers Chair Sun Oct 25 14:45–16:15 Coming soon to your clinic? New therapies and approaches for lung cancer Lung & thoracic cancers Talk Sun Oct 25 15:05–15:25 Vaccines: Promises, limitations and future directions Lung & thoracic cancers Satellite Mon Oct 26 18:30–20:00 Physicians' Education Resourse, LLC (PER) - Show Me the Data: HER2- Mutant NSCLC in Transition – Translating Evidence to Practice Lung & thoracic cancersBiomarkers & precision oncology Satellite Mon Oct 26 18:30–18:35 Welcome, introductions, program overview, and presession assessment Lung & thoracic cancersBiomarkers & precision oncology Satellite Mon Oct 26 19:50–20:00 Postsession assessment, Q&A and concluding remarks Lung & thoracic cancersBiomarkers & precision oncology |
Instantly find 20 buyers from Lausanne University Hospital (CHUV)
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction